Physician profile
James Lawrence Smith
NPI 1902079619
$2,643.00
in general payments reported to CMS, 2019-2025
27 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $18.15 · 2021: $429 · 2022: $103 · 2023: $408 · 2024: $913 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,705 · Education: $37.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.33 |
| Education | $37.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $303.57 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Pfizer INC. | $288.98 | 2023-2025 | |
| Abiomed | $213.79 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $198.80 | 2023-2025 | |
| Cvrx, INC. | $172.64 | 2021-2025 | Barostim Neo System |
| Philips North America LLC | $162.19 | 2019-2022 | |
| Medtronic, INC. | $161.47 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $142.80 | 2023-2025 | Wainua, Farxiga, Brilinta |
| Boston Scientific Corporation | $138.57 | 2023-2024 | Watchman Access System, Eluvia |
| Siemens Medical Solutions USA, INC. | $99.72 | 2024-2025 | Acuson Origin Diagnostic Ultrasound System |
| Intuitive Surgical, INC. | $97.29 | 2023 | Da Vinci Surgical System |
| Esperion Therapeutics, INC. | $73.35 | 2023-2024 | Nexletol |
| Merck Sharp & Dohme LLC | $64.90 | 2023-2025 | Verquvo |
| Medtronic Vascular, INC. | $64.35 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.62 | 2024-2025 | Jardiance |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $61.18 | 2024 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $55.36 | 2023-2025 | Eliquis, Camzyos |
| Amgen INC. | $51.21 | 2022-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $42.07 | 2024 | |
| Edwards Lifesciences Corporation | $34.99 | 2024 | |
| Chiesi USA, INC. | $34.42 | 2023-2025 | Kengreal, Cleviprex |
| Janssen Pharmaceuticals, INC | $27.45 | 2022 | |
| Heartflow, INC. | $26.95 | 2024 | |
| Lantheus Medical Imaging, INC. | $20.21 | 2023 | Definity |
| Cardiovascular Systems INC. | $17.09 | 2023 | Diamondback Peripheral |
| Cardiva Medical, INC. | $15.63 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.40 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.